Asan L, Gronen J, Peters L, Kleinschnitz C, Holle-Lee D, Benson S
Front Psychol. 2025; 16:1521978.
PMID: 40078436
PMC: 11897036.
DOI: 10.3389/fpsyg.2025.1521978.
Roldan Munoz S, Mol P, de Vries F, van Dijk P, Hillege H, Postmus D
Patient Prefer Adherence. 2025; 19:215-234.
PMID: 39882148
PMC: 11776401.
DOI: 10.2147/PPA.S486553.
Bush N, Cushnie A, Boissoneault J, Aghabeigi S, Alexander C, Staud R
J Pain Res. 2025; 18():189-201.
PMID: 39816204
PMC: 11733195.
DOI: 10.2147/JPR.S483157.
Gorner K, Spotts E, Geers A
J Behav Med. 2024; 47(6):1080-1093.
PMID: 39306633
PMC: 11499334.
DOI: 10.1007/s10865-024-00520-3.
Guiance I, Wallace L, Varga K, Niven A, Hosey M, Chitulangoma J
J Patient Exp. 2024; 11:23743735241272148.
PMID: 39130130
PMC: 11311157.
DOI: 10.1177/23743735241272148.
Risk factors associated with nocebo effects: A review of reviews.
Grosso F, Barbiani D, Cavalera C, Volpato E, Pagnini F
Brain Behav Immun Health. 2024; 38:100800.
PMID: 39021437
PMC: 11252084.
DOI: 10.1016/j.bbih.2024.100800.
The Roles of Endogenous Opioids in Placebo and Nocebo Effects: From Pain to Performance to Prozac.
Kerr P, Gregg J
Adv Neurobiol. 2024; 35:183-220.
PMID: 38874724
DOI: 10.1007/978-3-031-45493-6_10.
Exploring therapeutic interventions for functional neurological disorders: a comprehensive scoping review.
Sireci F, Ragucci F, Menozzi C, Cabboi M, Picchetto L, Bassi M
J Neurol. 2024; 271(7):3908-3927.
PMID: 38775932
DOI: 10.1007/s00415-024-12441-x.
Nocebo effects in systemic therapies for adult plaque psoriasis: A systematic review and meta-analysis.
Ma B, Park Y, Barber K, Mydlarski P
Front Med (Lausanne). 2024; 11:1373520.
PMID: 38601115
PMC: 11004429.
DOI: 10.3389/fmed.2024.1373520.
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
Jin R, Kruppert S, Scholz F, Bardoulat I, Karzazi K, Morand F
Rheumatol Ther. 2024; 11(3):523-537.
PMID: 38436916
PMC: 11111632.
DOI: 10.1007/s40744-024-00647-4.
Using hypnotic suggestion in the rehabilitation of working memory capacity after acquired brain injury: study protocol for a randomized controlled trial.
Eide L, Rike P, Reme S, Snekkevik H, Rossner S, Rosen G
Trials. 2024; 25(1):11.
PMID: 38167204
PMC: 10759527.
DOI: 10.1186/s13063-023-07867-z.
Cross-Cultural Adaptation and Measurement Properties of the Expectations for Treatment Scale (ETS) for Greek-Speaking Patients.
Karanasios S, Martzoukos N, Zampetakis N, Paleta D, Sampsonis T, Vasilogeorgis I
Cureus. 2023; 15(10):e46457.
PMID: 37927658
PMC: 10623487.
DOI: 10.7759/cureus.46457.
Mind games in dentistry: confounded evidence suggests a substantial nocebo response in dental impaction pain model.
Majid O
Evid Based Dent. 2023; 25(1):11-12.
PMID: 37875734
DOI: 10.1038/s41432-023-00940-1.
Can open label placebos improve pain and gluten tolerance via open label placebos in fibromyalgia patients? A study protocol for a randomised clinical trial in an outpatient centre.
Paschke L, Dreyer N, Worm M, Klinger R
BMJ Open. 2023; 13(10):e074957.
PMID: 37865404
PMC: 10603456.
DOI: 10.1136/bmjopen-2023-074957.
Motivational communication skills to improve motivation and adherence in cardiovascular disease prevention: A narrative review.
Xu L, Pinxten W, Vandereyt F, Falter M, Scherrenberg M, Kizilkilic S
Clin Cardiol. 2023; 46(12):1474-1480.
PMID: 37675783
PMC: 10716351.
DOI: 10.1002/clc.24128.
The Nocebo Effect.
Colloca L
Annu Rev Pharmacol Toxicol. 2023; 64():171-190.
PMID: 37585661
PMC: 10868531.
DOI: 10.1146/annurev-pharmtox-022723-112425.
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe.
Soriano-Arandes A, Brett A, Buonsenso D, Emilsson L, de la Fuente Garcia I, Gkentzi D
Front Public Health. 2023; 11:1175444.
PMID: 37564427
PMC: 10411527.
DOI: 10.3389/fpubh.2023.1175444.
Electrophysiological markers for anticipatory processing of nocebo-augmented pain.
Blythe J, Peerdeman K, Veldhuijzen D, Karch J, Evers A
PLoS One. 2023; 18(7):e0288968.
PMID: 37494313
PMC: 10370880.
DOI: 10.1371/journal.pone.0288968.
Patient experiences and opinions on medication review: a qualitative study.
Robberechts A, Van Loon L, Steurbaut S, De Meyer G, De Loof H
Int J Clin Pharm. 2023; 45(3):650-658.
PMID: 36862254
DOI: 10.1007/s11096-023-01541-9.
A randomized pharmacological fMRI trial investigating D-cycloserine and brain plasticity mechanisms in learned pain responses.
Thomaidou M, Blythe J, Veldhuijzen D, Peerdeman K, van Lennep J, Giltay E
Sci Rep. 2022; 12(1):19080.
PMID: 36351953
PMC: 9646732.
DOI: 10.1038/s41598-022-23769-7.